Antipsychotics and their potential for sedation
Hear what Professor Gregory Mattingly thinks about the sedative potential of antipsychotics, and what this can mean in both hospital and outpatient settings.
-
Body
REXULTI PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia
-
Body
Please review Approved Product Information before prescribing.
Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:REXULTI® is a registered trademark of H. Lundbeck A/S. REXULTI® is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.
Related
Related
Contributor
Dr Gregory Mattingly